Fundz

Smart Immune Appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, Strengthening C Suite with Seasoned Oncology Expertise

PRIVATEDec 04, 2023

Position

Chief Medical Officer

Company

Smart Immune

Rahim Fandi
rahim.fandi@smart-immune.com
United StatesBiotechnologyHealth CareMedicalTherapeutics

Description

Smart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, strengthening C suite with seasoned oncology expertise

Quick answer

Smart Immune Appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, Strengthening C Suite with Seasoned Oncology Expertise (December 4, 2023). Smart Immune is based in United States.

Who is the new Chief Medical Officer at Smart Immune?
Smart Immune named Rahim Fandi Chief Medical Officer, announced December 4, 2023.
What did Smart Immune announce on December 4, 2023?
Smart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, strengthening C suite with seasoned oncology expertise
What does Smart Immune do?
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T cell progenitor therapy platform to fully and rapidly re-arm the immune system against cancer and infection, enabling...
Where is Smart Immune based?
Smart Immune is based in United States.
Which similar companies made leadership changes around the same time?
TScan Therapeutics, Inc. (December 4, 2023), Myeloid (December 6, 2023), NYU Langone Health (December 1, 2023) and Diakonos Oncology (November 20, 2023) also announced leadership changes within 45 days of Smart Immune.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Smart Immune, and when

A new leader at Smart Immune brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Smart Immune raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Smart Immune, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Smart Immune. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Smart Immune

Location

United States

About

Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T cell progenitor therapy platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies for all. The company aims to radically improve outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is already in Phase I/II clinical trials, in the EU and the US, looking at the acceleration of complete immune recovery in patients fighting cancer and infection and undergoing allogeneic hematopoietic stem cell transplantation. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments against cancer, like persistent off-the-shelf CAR T cells. The Company is headquartered in Paris, France, at Paris Biotech Santé.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Smart Immune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Rahim
Likely contact at this company
••••••••@••••••••

See Rahim's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Smart Immune's next move

Learn about Strategic plan

Smart Immune changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.